Pages that link to "Q36295115"
Jump to navigation
Jump to search
The following pages link to Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells (Q36295115):
Displaying 10 items.
- Autocrine and paracrine growth inhibitors of breast cancer cells (Q33993767) (← links)
- Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4 (Q34000430) (← links)
- E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer (Q38321155) (← links)
- Butyrate inhibits pancreatic cancer invasion (Q40621145) (← links)
- A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade (Q40681889) (← links)
- Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. (Q40754112) (← links)
- Thrombospondin is sequentially expressed and then de-expressed during early pregnancy in the rat uterus (Q42477160) (← links)
- Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation (Q64117518) (← links)
- Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa (Q74374189) (← links)
- The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer (Q77461120) (← links)